Meet our dedicated Board of Directors, a group of experienced leaders committed to driving innovation and excellence in pharmaceutical research, ensuring our company’s mission to improve global health and deliver life-changing treatments.
Board-certified MD (Anesthesiology and Intensive Care) and DDS, Karolinska Institutet
Associate Professor and PhD in Physiology, Karolinska Institutet
Experience
Executive VP Global Medicines Development, Global Head Clinical Development, Global Therapy Area Head, and CEO, AstraZeneca AB Sweden.
Director and Chairman of the board, Karolinska university Hospital
Other assignments
Chairman/Non-Executive Board member of AnaMar AB, Alligator Bioscience AB, Elypta AB, Flerie Invest AB, Mereo BioPharma Group Plc, and Xspray Pharma AB
PhD in Physical Chemistry from Stockholm University.
Post-doc at FMP Berlin
Experience
Venture Partner at Flerie
CEO at Empros Pharma
Senior project manager at the Royal Academy of Engineering Sciences
Project manager at Sidec Technologies.
